Clinical Trial Update: Inhaled Mannitol on Mucociliary Clearance in Moderate to Severe Cystic Fibrosis [Phase 4]

View source ↗

Summary

Phase 4 trial update reporting results of inhaled mannitol on mucociliary clearance in moderate-to-severe cystic fibrosis; results were posted 2026-01-07.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cystic Fibrosis

Drugs mentioned

• Bronchitol (mannitol)

Snippet

Sponsor: University of North Carolina, Chapel Hill | Conditions: Cystic Fibrosis | Phase 4 | Status: COMPLETED | Results posted: 2026-01-07